Results
Trial
Research Area
Duration
Locations
Designed to develop a standard operating procedure to establish a storage bank for specimens for future HIV DNA analyses. Informed…
Open and enrolling
Hepatitis, HIV comorbidities and complications, HIV Cure, HIV Treatment, Tuberculosis
A5243: Non-US Genomic Sampling
Collecting blood and saliva samples from former and current ACTG study participants for future HIV-related genetic testing. This is a…
Closed to accrual
Hepatitis, HIV comorbidities and complications, HIV Cure, HIV Treatment, Tuberculosis
This trial is in household contacts (HHC) at high risk for developing multidrug resistant tuberculosis (MDR-TB) which is an infection…
Open and enrolling
Tuberculosis
All participants will be in this study for 96 weeks.
This study is for participants who have pulmonary tuberculosis (TB), a bacterial infection in their lungs. Isoniazid (INH) is a…
Closed to accrual
Tuberculosis
About 23 days
AHRC (pronounced “ARC”) is a study of differences and changes over time in HIV reservoirs (groups of HIV-infected cells that…
Open and enrolling
HIV Cure, Treatment Experienced
Participants will be expected to stay in the study for about 7 years.
You are being asked to take part in this research study because you are infected with HIV, the virus that…
Closed to accrual
HIV comorbidities and complications
Participants will be followed for 366 weeks (7 years).
In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin)…
Closed to accrual
HIV comorbidities and complications
You will be in this study for about 36 to 96 months depending on when you enroll in the study.
A5341s: A5321 Sampling Substudy Longitudinal Sampling Substudy of A5321 is collecting information from measures of different HIV reservoirs, including…
Open and enrolling
HIV Cure
This is a randomized study, which means, by chance, you will be in one of three groups. You have an…
Closed to accrual
Tuberculosis
24 weeks on study treatment, followed by 104 weeks follow-up, for a total length of 128 weeks
Will evaluate whether starting antiretroviral drugs very early in HIV infection will limit the virus from getting into hidden areas…
Closed to accrual
HIV Cure
The duration of the study is up to 72 weeks (a year and a half).
Since the early days of the HIV epidemic cytomegalovirus (CMV) has been one of the most common and devastating opportunistic…
Closed to accrual
HIV comorbidities and complications
About 2 years (96 weeks).